d.ferreira

TL2 · Bochum

Contributes reviews on supplier material. Based in Bochum.

Joined 17 June 2025 · last posted 1d

93 posts, newest first. Showing up to 150.

[2026 update] Detection wavelength and why 214 nm and 280 nm disagree Replied, post #74 · Analytics › HPLC & UHPLC · 27 Jul 2026 · 3 likes Before anything else: what was the gradient, and at what wavelength? Area percent at different wavelengths is not the same number even on the same sample because…
What to bring: records that a clinician can actually use — a second dataset Replied, post #82 · Clinical › Prescriber conversations · 27 Jul 2026 · 1 like Bringing a record of symptoms with dates and severities makes an assessment materially easier and is the single most useful preparation.
GHRH analogues versus ghrelin mimetics: different mechanisms, conflated discussion Replied, post #53 · Compounds › Secretagogues & GH axis · 26 Jul 2026 · 12 likes Post #51 put the caveat in the right place and I want to underline it. Filing a mild objection to the consensus on GHRH analogues versus ghrelin mimetics. Mild because…
Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #66 · Compounds › Retatrutide · 16 Jul 2026 · 12 likes Agreed on retatrutide discussion, with one qualification that I think matters. The reasoning holds for the case as described. Change the starting assumption and it does…
Immortal time bias in a claims-database study — one year on Replied, post #24 · Evidence › Study critique · 15 Jul 2026 · 11 likes Everything in post #20 holds. The case it does not cover is the one I have. What I want from this Immortal time bias thread is the list of things that would need to be…
Submitting a sample: the process end to end Replied, post #76 · Sourcing › Independent verification · 12 Jul 2026 · 2 likes The record shows what was measured. Everything beyond that is inference and this site tries to keep the line visible. A qualification I should have led with rather than…
Heart failure with preserved ejection fraction: symptom endpoints Replied, post #18 · Clinical › Comorbidities · 8 Jul 2026 · 0 likes Heart failure with preserved ejection would be much easier to settle if anyone reported the denominator. Almost nobody reports the denominator.
How shortages have affected compounding permissions Replied, post #19 · Access › Shortages · 6 Jul 2026 · 32 likes Both are useful and different. The notice tells you the national position; the account tells you what is happening on the ground.
HbA1c lag and what it can and cannot tell you at eight weeks — one year on Replied, post #16 · Clinical › Bloodwork · 4 Jul 2026 · 0 likes Repeat before acting is standard practice for an isolated abnormal result on most analytes, and it is standard for a reason. If anyone has run this properly I would…
Personal or family history of medullary thyroid carcinoma Replied, post #32 · Safety › Contraindications · 30 Jun 2026 · 0 likes A history of pancreatitis appears in the cautions and the decision around it needs somebody who knows the history rather than a general rule.
[2026 update] Travelling with an injectable: documentation and practicalities Replied, post #40 · Access › International · 27 Jun 2026 · 2 likes Coming back to post #38, because the follow-up matters more than the original answer. Country-by-country legality: compound approval and legal status differ…
A reconstituted vial's beyond-use date and the reasoning behind common figures Replied, post #127 · Practice › Storage & stability · 10 Jun 2026 · 1 like Visible particulate is a strong signal in the other direction: it is a reason to stop and ask rather than to filter and proceed.
Reading a trial's population section before its results Replied, post #90 · Evidence › Trials · 5 Jun 2026 · 0 likes Where I part company with post #88, and it is a narrow parting. Effect sizes in a trial population reflect adherence achieved under trial conditions, which is generally…
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #83 · Practice › Reconstitution · 1 Jun 2026 · 2 likes Narrowing post #80, because the general version has more than one answer. Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither…
Does dual agonism explain the effect size, or is it dose? Replied, post #7 · Compounds › Tirzepatide · 29 May 2026 · 0 likes Answering the question post #5 raises rather than the one it answers. SURMOUNT-4's randomised withdrawal design is the strongest available evidence about what happens…
The anatomy of a question that gets answered within an hour Replied, post #58 · Start Here › How to Ask · 27 May 2026 · 0 likes It is fine to say you cannot explain why you are asking. Nobody will press, and the technical part of the question can usually be answered without the context. Not a…
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #68 · Practice › Reconstitution · 23 May 2026 · 27 likes Where I part company with post #64, and it is a narrow parting. A 10 mg vial reconstituted three different ways: 1 mL diluent gives 10 mg/mL, 2 mL gives 5 mg/mL, 4 mL…
A checklist for reading a certificate in under two minutes Replied, post #21 · Analytics › COA interpretation · 15 May 2026 · 16 likes When method identifiers are missing: "reversed-phase HPLC" is less specific than "reversed-phase HPLC at 214 nm on a C18 column with a 10 to 40% acetonitrile gradient…
About the Insurance & coverage category Replied, post #5 · Access › Insurance & coverage · 30 Apr 2026 · 13 likes Quantity limits are a separate decision from coverage and have their own exception route.
Comparing documentation quality across the directory, tabulated Started this topic · Sourcing › Vendor reports · 29 Apr 2026 · 1 like Comparing documentation quality across the directory, tabulated — setting out what I have, and where I think it stops being reliable. I have spent a fortnight trying to…
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ — a second dataset Replied, post #42 · Sourcing › Independent verification · 28 Apr 2026 · 30 likes Summarising the Janoshik thread so far, since it is long and the answer is buried: the first reply has the method, the fourth has the correction to it, and the rest is…
Coming back to: Reconciling a supplier certificate with an independent result Started this topic · Sourcing › Vendor reports · 28 Apr 2026 · 10 likes Posting this under the heading it deserves: Reconciling a supplier certificate with an independent result Everything below is what sits behind that. Reconciling a…
[2026 update] 0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #60 · Devices › Syringes & needles · 25 Apr 2026 · 14 likes The arithmetic in post #59 is right; the assumption feeding it is the part to check. U-100 means the barrel is graduated for a solution containing one hundred units of…
[2026 update] Charge states for a 4 kDa peptide, worked through Replied, post #79 · Analytics › Mass spectrometry · 13 Apr 2026 · 0 likes Calibration state at the time of the run determines whether the ppm figure means anything. A report that states when the instrument was last calibrated is unusual and…
Pregnancy and pregnancy planning: contraindication and washout Replied, post #108 · Clinical › Special populations · 13 Apr 2026 · 25 likes That is the distinction I keep failing to hold on to. Written down now.
The "under review" status pill and when a moderator applies it Replied, post #42 · Evidence › Preprints · 28 Mar 2026 · 0 likes Post #38 and I disagree about the size of the effect, not about the direction. If you cite a preprint in a maintained document here, the convention is to label it in…
The lowest dose that does anything: is that a real question? Replied, post #108 · Practice › Dosing & titration · 8 Mar 2026 · 18 likes Building on post #107 rather than restating it. When a dose reduction is the correct response to a side effect: if a side effect is dose-dependent (nausea,…
[2026 update] What a purity-only report leaves out Replied, post #39 · Sourcing › Independent verification · 1 Mar 2026 · 0 likes Purity-only was covered in the wiki last year and the page has a review date on it, which is a better starting point than my memory of a thread.
Why one laboratory's 98.4% and another's 96.1% may not contradict — one year on Replied, post #10 · Analytics › Method validation · 21 Feb 2026 · 0 likes I had written a reply contradicting post #8 and deleted it. Here is what survived. An independent laboratory's method being different from the supplier's is not a…
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #35 · Practice › Dosing & titration · 16 Feb 2026 · 25 likes Sensible. I would want the same detail before I acted on it either.
Revisiting: Language barriers in accessing a prescription abroad Replied, post #109 · Access › International · 14 Feb 2026 · 24 likes Post #105 and I disagree about the size of the effect, not about the direction. I would put moderate confidence on the mainstream reading of Language barriers in…
Why semaglutide solutions can look faintly opalescent and when that matters Replied, post #64 · Compounds › Semaglutide · 6 Feb 2026 · 0 likes One more thing on semaglutide solutions that took me far too long to see: the two figures people quote are not measuring the same quantity. Once you notice that, the…
MHRA statements, read directly Replied, post #67 · Regional › UK & Ireland · 13 Jan 2026 · 1 like Noted, and I have changed what I was going to do on the strength of it.
Personal import allowances, compared — a second dataset Replied, post #47 · Access › International · 5 Jan 2026 · 27 likes Agreed on Personal import allowances, with one qualification that I think matters. The reasoning holds for the case as described. Change the starting assumption and it…
[2026 update] What a good consultation looks like from the other side Replied, post #10 · Clinical › Prescriber conversations · 4 Jan 2026 · 27 likes Post #7 answers the question as asked. The question underneath it is different. Prescription logistics: confirm whether it will be filled locally, requires mail order,…
Which panel is worth repeating and which is worth ignoring — a second dataset Replied, post #38 · Clinical › Bloodwork · 27 Dec 2025 · 12 likes Confirming post #37 from a second method, which matters more than confirming it from a second person. On panel, the part that usually goes wrong is that the question is…
Request declined, with reasoning — what changed since Replied, post #2 · Meta › Feature requests · 25 Dec 2025 · 12 likes I had read the opposite somewhere and cannot now find where, which tells me something.
Half-life, steady state, and accumulation worked through — a second dataset Replied, post #42 · Pharmacology › Pharmacokinetics · 21 Dec 2025 · 5 likes If you are new and reading this thread for the answer to Half-life: the answer is conditional, the conditions are in the third reply, and the rest of the thread is…
Heterogeneity as information rather than as a nuisance Replied, post #27 · Evidence › Meta-analyses · 16 Dec 2025 · 9 likes Bookmarking this. I will come back when I have something worth adding.
Reused chromatograms across lots: how to spot it Replied, post #8 · Analytics › COA interpretation · 14 Dec 2025 · 0 likes Post #4 describes the usual case. This is about the unusual one. A chromatogram supplied as a small image is legible for peak shape and not for baseline detail. That is…
What pooling buys you and what it destroys Replied, post #76 · Evidence › Meta-analyses · 26 Nov 2025 · 7 likes Worth stating the null on pooling buys before we explain it: the observation may be nothing. That possibility deserves a sentence and usually does not get one.
Pharmaceutical compounding rules, summarised from primary sources — a second dataset Replied, post #26 · Sourcing › Regulatory · 12 Nov 2025 · 15 likes If you can confirm or contradict a position for your own region, please date the answer. An undated regional claim is the least useful thing in this category.
The anatomy of a question that gets answered within an hour — the long version Replied, post #53 · Start Here › How to Ask · 3 Nov 2025 · 14 likes Timeline questions need the timeline. Dates, in order, with what happened on each. "A while ago" and "recently" are the two least useful words in a question of this…
Sleep quality changes during weight loss — what changed since Replied, post #34 · Wellbeing › Sleep · 21 Oct 2025 · 3 likes That is consistent with mine, for whatever one more account is worth.
Older adults, sarcopenia risk, and the trade-off nobody quantifies Replied, post #10 · Clinical › Special populations · 8 Oct 2025 · 1 like Older adults would be much easier to settle if anyone reported the denominator. Almost nobody reports the denominator.
What pooling buys you and what it destroys Replied, post #36 · Evidence › Meta-analyses · 6 Oct 2025 · 8 likes This is the first time the answer has come with its own limits attached. Appreciated.
What a purity-only report leaves out Replied, post #31 · Sourcing › Independent verification · 1 Oct 2025 · 0 likes Everything in post #27 holds. The case it does not cover is the one I have. The question underneath purity-only is usually "how would I tell?" rather than "what is…
The most useful thing you learned here that was not the answer you came for — a second… Replied, post #50 · Lounge › Off topic · 22 Sep 2025 · 0 likes Adjacent and interesting: you might post something about nutrition, bioavailability from a food perspective, or the sociology of weight. Adjacent to this community's…
Substitution between formats during a shortage Replied, post #59 · Access › Shortages · 18 Sep 2025 · 15 likes Managing an unplanned gap: if a shortage causes a gap in treatment, the questions are how long the gap will be and how that affects your condition. Discussing with your…
Revisiting: Reading a denial letter as a specification for your appeal Replied, post #117 · Access › Insurance & coverage · 12 Sep 2025 · 0 likes Appeal deadlines are strict and are stated in the letter. Missing one is the most avoidable way to lose. I looked this up rather than remembered it, which is the right…
Aggregated purity results across four services, with caveats — a second dataset Replied, post #123 · Data & Tools › Datasets · 11 Sep 2025 · 6 likes That is a cleaner way of putting what I was circling around.
A ten-fold dose error caught before injection Replied, post #95 · Devices › Syringes & needles · 6 Sep 2025 · 14 likes Reusing a needle blunts it and there is no benefit to offset that. The second injection with the same needle is the one people describe as painful. Reporting the…
Follow-up: Journal club: orforglipron phase 2 and the non-peptide question Replied, post #52 · Evidence › Journal club · 27 Aug 2025 · 9 likes The most common failure mode is spending fifty minutes on the effect size and ten on the population. Reversing that ratio would improve most sessions.
[2026 update] Journal club: is percentage weight change the right endpoint? Replied, post #14 · Evidence › Journal club · 11 Aug 2025 · 15 likes The most common failure mode is spending fifty minutes on the effect size and ten on the population. Reversing that ratio would improve most sessions.
A request that was declined, and the reasoning — a second dataset Replied, post #9 · Documentation › Wiki requests · 5 Aug 2025 · 8 likes I had written a reply contradicting post #5 and deleted it. Here is what survived. Scope the request narrowly. A page about one thing gets written and stays current; a…
Why catalogue breadth is not evidence of anything — what changed since Replied, post #12 · Compounds › Other compounds · 4 Aug 2025 · 0 likes Confirming post #11 from a second method, which matters more than confirming it from a second person. How to research a compound with no human data: mechanistic…
Domestic fridge temperature mapping: a cheap experiment — what changed since Replied, post #156 · Devices › Cold chain · 4 Aug 2025 · 7 likes Fine by me. I had wanted a stronger conclusion and there is not one available.
How to research a compound with no human data without deceiving yourself Replied, post #90 · Compounds › Other compounds · 3 Aug 2025 · 0 likes Answering the question post #88 raises rather than the one it answers. Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical…
When a preprint is the best available evidence and we say so Replied, post #17 · Evidence › Preprints · 2 Aug 2025 · 0 likes Answering the question post #13 raises rather than the one it answers. What I would check first on preprint is whether the thing being measured moved or whether the way…
"Greater than or equal to 99%" as a specification rather than a result Replied, post #10 · Analytics › COA interpretation · 22 Jul 2025 · 32 likes A chromatogram supplied as a small image is legible for peak shape and not for baseline detail. That is enough to sanity-check an integration and not enough to…
Meeting a protein target on a suppressed appetite Replied, post #9 · Nutrition & Training › Protein & intake · 11 Jul 2025 · 4 likes The mechanism is not mysterious. Substantial energy restriction with inadequate protein and no resistance stimulus loses lean tissue as well as fat.
Coming back to: Oxidation and deamidation mass shifts, tabulated Replied, post #17 · Analytics › Mass spectrometry · 29 Jun 2025 · 0 likes Common adducts: sodium adds ≈22, potassium adds ≈38 compared to hydrogen. A [M+Na]+ peak is common and its mass is predictable from the base mass. I have deliberately…
Repeatability versus intermediate precision Replied, post #78 · Analytics › Method validation · 27 Jun 2025 · 28 likes My position on repeatability versus intermediate precision is current rather than settled. I have revised it once already and I expect to again, so treat it accordingly.
The CagriSema phase 2 paper and what a fixed combination buys Replied, post #56 · Compounds › Cagrilintide & amylin analogues · 16 Jun 2025 · 0 likes Reading the phase 2 paper: it establishes tolerability and efficacy in a selected population on a defined dose escalation. It does not establish the lowest effective…
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #108 · Compounds › Tirzepatide · 12 Jun 2025 · 0 likes Clear enough that I do not think I have a follow-up, which is unusual.
Journal club: SURMOUNT-4 and continuation versus withdrawal — a second dataset Replied, post #48 · Evidence › Journal club · 10 Jun 2025 · 14 likes On post #46 — agreed on the reasoning, with one qualification. Two questions I would want answered before drawing anything from the SURMOUNT-4 and continuation versus…
Reconstituting a multi-strength kit without mixing yourself up Replied, post #82 · Practice › Reconstitution · 7 Jun 2025 · 10 likes The practical version of reconstituting a multi-strength kit is three sentences long. The rigorous version is three pages and reaches the same conclusion with the…
Anxiety in the first weeks: drug, situation, or both Replied, post #97 · Wellbeing › Mental health · 3 Jun 2025 · 1 like Where I part company with post #95, and it is a narrow parting. I have no financial interest in anything named in this thread and I want to say so before I comment on…
A claim built entirely on a subgroup analysis Replied, post #66 · Evidence › Study critique · 31 May 2025 · 4 likes Appreciated. The plain phrasing does more work here than a longer post would.
Revisiting: German, French and Dutch differences, compared Replied, post #26 · Regional › European Union · 27 May 2025 · 0 likes German came up in a thread eighteen months ago and was answered well. I cannot find it, which is itself the problem, so here is the reconstruction.
Request: a diff view for wiki revisions — the long version Replied, post #4 · Meta › Feature requests · 26 May 2025 · 1 like An observation about diff view for wiki revisions that I cannot explain and am posting anyway, on the principle that unexplained observations are more useful public…
Reading a regulatory notice rather than an article about it — what changed since Replied, post #7 · Sourcing › Regulatory · 24 May 2025 · 3 likes Anything written here about regulatory status should be assumed stale after twelve months, which is why the documentation pages carry review dates. If it helps: the…
Half-life, steady state, and accumulation worked through Replied, post #10 · Pharmacology › Pharmacokinetics · 22 May 2025 · 0 likes Building on post #9 rather than restating it. Half-life was covered in the wiki last year and the page has a review date on it, which is a better starting point than my…
Pregnancy as an absolute contraindication Replied, post #63 · Safety › Contraindications · 19 May 2025 · 8 likes Where I would push back on the pregnancy consensus is the confidence, not the direction. The direction looks right. The confidence is borrowed.
Second pass at: Designing a personal experiment that could change your mind Replied, post #11 · Research Methods › N-of-1 designs · 17 May 2025 · 2 likes A single-person experiment can be genuinely informative if it has a pre-specified outcome, a defined period, and a plan written before the data arrives. Most accounts…
A report I filed that turned out to be wrong, and the correction Replied, post #43 · Sourcing › Vendor reports · 7 May 2025 · 1 like Where I part company with post #39, and it is a narrow parting. Do not adjust a reported figure. Post what the laboratory said and put your interpretation in a separate…
When to stop reading forums, including this one — the long version Replied, post #4 · Wellbeing › Mental health · 28 Apr 2025 · 25 likes A change that came on with an escalation and settled is a different observation from one that has persisted for months. Stating my assumptions rather than smuggling…
Micronutrient status when intake falls substantially — a second dataset Replied, post #13 · Clinical › Bloodwork · 28 Apr 2025 · 17 likes Time of day: some biomarkers vary across the day. Cortisol in the morning differs from cortisol in the evening. Comparing results from different times of day is…
Follow-up: Journal club: the retatrutide phase 2 obesity paper Replied, post #23 · Evidence › Journal club · 8 Apr 2025 · 3 likes TRIUMPH (ongoing): Retatrutide phase 3. No results yet. Nothing should be attributed to it because it has not finished. When it does, this discussion will return to it.
What happens after your first post: likes, trust levels, and why none of it matters much Replied, post #11 · Start Here › Welcome · 26 Mar 2025 · 0 likes Off-topic posts that do not belong here belong in the Lounge instead. You are not in trouble if a moderator moves your post — they are just routing it to the right…
How compounding permissions changed when supply normalised Replied, post #26 · Sourcing › Regulatory · 4 Mar 2025 · 5 likes Where a claim about legality is made here, the useful follow-up is which instrument it rests on. Most such claims turn out to rest on a forum post.
Validating a method you did not develop — does this still hold? Replied, post #69 · Analytics › Method validation · 4 Mar 2025 · 0 likes I had written a reply contradicting post #65 and deleted it. Here is what survived. Range: the concentration range over which the method has been validated. Going…
What the published dose-response for semaglutide actually looks like above 2.4 mg — a… Replied, post #86 · Compounds › Semaglutide · 3 Mar 2025 · 5 likes Post #84 describes the usual case. This is about the unusual one. I keep a log for published dose-response for semaglutide specifically because my memory of it turned…
Reading an MS report that only gives you a single number Replied, post #19 · Analytics › Mass spectrometry · 28 Feb 2025 · 19 likes Quantitation by MS: most quantitation is done by LC-UV detection at 214 nm, not by MS, because extinction coefficients are better known. MS can quantify if an internal…
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #66 · Compounds › Cagrilintide & amylin analogues · 15 Feb 2025 · 6 likes Reconstitution at higher concentrations is worth avoiding for aggregation-prone material. The published formulation work generally uses lower concentrations than people…
Oral semaglutide bioavailability and its variability between people — a second dataset Replied, post #78 · Compounds › Oral incretins · 27 Dec 2024 · 0 likes Worth separating two things that post #76 runs together. Why an oral formulation is a formulation achievement: the molecule is the same but the tablet is novel. Getting…
Molecular mass of semaglutide and why the figure differs between sources — does this… Replied, post #35 · Compounds › Semaglutide · 20 Dec 2024 · 0 likes The STEP programme populations were selected: enrollment criteria required baseline body mass index over 30, no recent blood pressure crisis, no recent retinopathy, no…
Reading a supplementary appendix and finding the interesting part Replied, post #44 · Evidence › Trials · 15 Dec 2024 · 0 likes Post #41 is the version of this I will quote in future. One addition. Absolute and relative effects answer different questions. Write down the event rate in each arm…
A revision dispute resolved on the topic rather than in the history — a second dataset Replied, post #45 · Meta › Wiki maintenance · 23 Nov 2024 · 0 likes Building on post #42 rather than restating it. The practical version of revision dispute resolved is three sentences long. The rigorous version is three pages and…
Why we hide unevidenced fraud accusations and log the hiding Replied, post #14 · Sourcing › Red flags · 10 Nov 2024 · 11 likes The guidelines draw that line for a practical reason as much as a fair one: reports accumulate into something useful and allegations do not.
Coming back to: Research-use-only labelling: what it means and what it does not Replied, post #23 · Sourcing › Regulatory · 7 Nov 2024 · 3 likes I had read the opposite somewhere and cannot now find where, which tells me something.
Splitting a vial for two laboratories: how to do it without ruining both — what changed… Replied, post #73 · Sourcing › Independent verification · 20 Sep 2024 · 12 likes I have three months of notes on Splitting a vial and the honest summary is that the trend is real and the week-to-week numbers are noise. I nearly drew the opposite…
The C-cell question: rodent findings and their human context — what changed since Replied, post #34 · Compounds › Semaglutide · 3 Sep 2024 · 17 likes I read post #32 twice before replying, because I had assumed the opposite. Cardiovascular data in people without diabetes is the specific contribution of SELECT, and it…